Jim Simons
HRMY icon

Jim Simons’s Harmony Biosciences HRMY Stock Holding History

Jim Simons’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.2M Buy
1,077,371
+6,900
+0.6% +$226K 0.05% 494
2025
Q4 		$40.1M Sell
1,070,471
-66,600
-6% -$2.19M 0.06% 350
2025
Q3 		$31.3M Buy
1,137,071
+207,600
+22% +$7.15M 0.04% 533
2025
Q2 		$29.4M Buy
929,471
+89,100
+11% +$2.87M 0.04% 552
2025
Q1 		$27.9M Buy
840,371
+271,700
+48% +$9.74M 0.04% 527
2024
Q4 		$19.6M Buy
568,671
+76,071
+15% +$2.61M 0.03% 680
2024
Q3 		$19.7M Sell
492,600
-103,200
-17% -$3.62M 0.03% 672
2024
Q2 		$18M Buy
595,800
+215,700
+57% +$6.49M 0.03% 644
2024
Q1 		$12.8M Buy
380,100
+121,600
+47% +$3.9M 0.02% 862
2023
Q4 		$8.35M Sell
258,500
-33,600
-12% -$938K 0.01% 1038
2023
Q3 		$9.57M Sell
292,100
-118,300
-29% -$4.11M 0.02% 948
2023
Q2 		$14.4M Sell
410,400
-55,400
-12% -$1.91M 0.02% 837
2023
Q1 		$15.2M Buy
465,800
+123,100
+36% +$5.61M 0.02% 866
2022
Q4 		$18.9M Buy
342,700
+17,700
+5% +$973K 0.03% 734
2022
Q3 		$14.4M Buy
325,000
+33,200
+11% +$1.62M 0.02% 841
2022
Q2 		$14.2M Buy
291,800
+149,300
+105% +$6.72M 0.02% 915
2022
Q1 		$6.93M Buy
142,500
+7,700
+6% +$314K 0.01% 1369
2021
Q4 		$5.75M Buy
134,800
+95,400
+242% +$3.8M 0.01% 1439
2021
Q3 		$1.51M Buy
39,400
+27,600
+234% +$889K ﹤0.01% 2306
2021
Q2 		$333K Buy
+11,800
New +$354K ﹤0.01% 3109

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jim Simons's HRMY Position: Q1 2026 in Review

Jim Simons increased its Harmony Biosciences (HRMY) stake by 0.64% in Q1 2026, buying an estimated $226K and bringing the position to 1,077,371 shares worth $30.2M. The position accounts for 0.05% of the portfolio, ranked #494.

Jim Simons first reported a position in HRMY in Q2 2021 and has held it in 20 quarters since. The position peaked at $40.1M in Q4 2025. 310 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Jim Simons held 1,077,371 shares of Harmony Biosciences worth $30.2M as of Q1 2026.
  • Jim Simons bought 6,900 Harmony Biosciences shares in Q1 2026, an estimated $226K.
  • Harmony Biosciences made up 0.05% of Jim Simons's portfolio in Q1 2026, its #494 holding.
  • Jim Simons first reported a position in Harmony Biosciences in Q2 2021 and has held it in 20 quarters since.
  • Jim Simons's Harmony Biosciences position peaked at $40.1M in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.